Authors:
HOFFMAN K
HOLMES FA
FRASCHINI G
ESPARZA L
FRYE D
RABER MN
NEWMAN RA
HORTOBAGYI GN
Citation: K. Hoffman et al., PHASE I-II STURDY - TRICIRIBINE (TRICYCLIC NUCLEOSIDE PHOSPHATE) FOR METASTATIC BREAST-CANCER, Cancer chemotherapy and pharmacology, 37(3), 1996, pp. 254-258
Authors:
WALTERS RS
THERIAULT RL
BOOSER DJ
ESPARZA L
HORTOBAGYI GN
Citation: Rs. Walters et al., PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON (RIFN-ALPHA) AND CONTINUOUS-INFUSION 5-FLUOROURACIL IN METASTATIC BREAST-CANCER, Journal of immunotherapy with emphasis on tumor immunology, 18(3), 1995, pp. 185-187
Authors:
VALERO V
BOOSER D
THERIAULT R
ESPARZA L
GAGNON S
HORTOBAGYI G
Citation: V. Valero et al., PILOT-STUDY OF TAXOTERE IN TAXOL-RESISTANCE METASTATIC BREAST-CANCER (TRMBC), European journal of cancer, 31A, 1995, pp. 384-384
Authors:
VALERO V
ESPARZA L
PATEL S
THERIAULT R
PAZDUR R
AYOUB JP
QASIM M
RODRIGUEZ E
BELLET R
HORTOBAGYI G
Citation: V. Valero et al., PHASE-I STUDY OF CYCLOPHOSPHAMIDE AND DOCETAXEL (TAXOTERE(R)) IN SOLID TUMORS, European journal of cancer, 31A, 1995, pp. 972-972
Authors:
VALERO V
HOLMES FA
WALTERS RS
THERIAULT RL
ESPARZA L
FRASCHINI G
FONSECA GA
BELLET RE
BUZDAR AU
HORTOBAGYI GN
Citation: V. Valero et al., PHASE-II TRIAL OF DOCETAXEL - A NEW, HIGHLY EFFECTIVE ANTINEOPLASTIC AGENT IN THE MANAGEMENT OF PATIENTS WITH ANTHRACYCLINE-RESISTANT METASTATIC BREAST-CANCER, Journal of clinical oncology, 13(12), 1995, pp. 2886-2894
Authors:
WALTERS RS
THERIAULT RL
HOLMES FA
ESPARZA L
HORTOBAGYI GN
Citation: Rs. Walters et al., PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON AND RECOMBINANT INTERLEUKIN-2 IN METASTATIC BREAST-CANCER, Journal of immunotherapy with emphasis on tumor immunology, 16(4), 1994, pp. 303-305
Authors:
BUZDAR AU
ESPARZA L
NATALE R
CODY R
CALZONE K
BENSON AB
SHEEHAN T
BERRY W
Citation: Au. Buzdar et al., LORAZEPAM-ENHANCEMENT OF THE ANTIEMETIC EFFICACY OF DEXAMETHASONE ANDPROMETHAZINE - A PLACEBO-CONTROLLED STUDY, American journal of clinical oncology, 17(5), 1994, pp. 417-421